Skip to content
★ Sign in to follow
SE

Shenzhen Edge Medical Co., Ltd. - B - H Shares Stock: price and insider trades · Hong Kong

HK·Mcap HK$10.1BHealth Care

2 insiders bought €9.6M of shares over the last 90 days, the latest by GAO Yuanqian, filed 03 Nov 2026.

Cluster: 2 buyers in 30 days

Shenzhen Edge Medical Co., Ltd. - B - H Shares: what insiders have been doing

Shenzhen Edge Medical Co., Ltd. - B - H Shares belongs to the Health Care sector. Filings by its managers are published through HKEX. From 8 November 2025 to 8 November 2026, the disclosure feed for Shenzhen Edge Medical Co., Ltd. - B - H Shares logged 21 filings by 2 insiders.

Only purchases show up on the open market, 21 purchases in all worth €9.6M, filed by 2 insiders. The amount is not disclosed for 2 filings. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. On the buying side, the filings list 2 senior executives among the declarants. One trade stands out by size: a purchase of €1.1M from GAO Yuanqian, disclosed on 30 October 2026, or 0.085% of market capitalisation.

In all, 19 purchases were made within 30 days of a purchase by another insider of the company. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. The last purchase on record was published on 3 November 2026, which is 6 days ago. Typically, a trade is published a median of 5 days after it takes place. The shorter that gap, the sooner other investors can see what insiders have done.

Across the 1,323 companies tracked on its exchange, the median is 4 filings; at 21 filings, this issuer sits above that mark. Since 2026, the database holds 21 purchases and no sales by insiders of the company.

Elsewhere in the same sector, our signals recently picked up insider purchases at Dynavox Group AB and Vetoquinol SA. Source: insider filings from HKEX. Past trades are no guide to future returns.

Insider Decl.
40
Thresholds
n/a
Buy Volume
€10M
21 ops. · all time
Sell Volume
n/a
n/a

Who traded when

BuySale
GAO Yuanqian19 buys
WANG Jianchen2 buys

Since the insiders bought

  • Filed 29 Oct 2026 · 11 days ago · €296k
    -16.3%
    Entry HK$31.46 · Close 06 Nov 2026 HK$26.34

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 20,047 of 26,911 companies
34.8
score / 100
Value
30
Quality
40
FCF yld-1.9%
Earn yld-0.9%
EV/EBITDA·
ROE-1.1%
Gross mgn66%
Net mgn-19%
Debt/EBITDA·
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

HK$26.20
Analyst consensus
5 analysts
1.40/5
HK$51.68Target HK$56.98(+117%)HK$60.35
Income statement
RevenueHK$455.7M
Gross profitHK$300.7M66% margin
EBITDA-HK$62.4M-14% margin
Net income-HK$88.6M-3.0% margin
Valuation
PER (forward)49.7x
P/Book3.8x
Balance sheet & cash
Market capHK$10.1B
Total debtHK$9.9M
Free Cash Flow-HK$197.9M
Debt / Equity2%
Profitability & ownership
ROE-1.1%
ROA0.4%
% insiders54.3%
% institutions36.6%
Last declaration on 3 November 2026
Declarations40 total
  • ▲
    DirectorExecutives
    3M HKD34HKEX
    85,500 shares@ HK$31.37790.024% mcap3.2% of flowShareXHKGHKEX:DA20261103E00256
    Canonical exit: 27 Jan 2027 (T+90)
  • ▲
    DirectorExecutives
    4M HKD41HKEX
    119,200 shares@ HK$31.27040.033% mcap58.0% of flowShareXHKGHKEX:DA20261103E00248
    Canonical exit: 28 Jan 2027 (T+90)
  • ▲
    DirectorExecutives

    Same trade as the filing by GAO Yuanqian, counted once

    3M HKD38HKEX
    85,500 shares@ HK$31.37790.024% mcap42.0% of flowShareXHKGHKEX:DA20261103E00246
    Canonical exit: 27 Jan 2027 (T+90)
  • ▲
    DirectorExecutives

    Same trade as the filing by WANG Jianchen, counted once

    4M HKD35HKEX
    119,200 shares@ HK$31.27040.033% mcap4.4% of flowShareXHKGHKEX:DA20261103E00258
    Canonical exit: 28 Jan 2027 (T+90)
  • ▲
    DirectorExecutives
    10M HKD38HKEX
    300,000 shares@ HK$33.30340.085% mcap12.9% of flowShareXHKGHKEX:DA20261030E00115
    Canonical exit: 26 Jan 2027 (T+90)
  • ▲
    DirectorExecutives

    Same trade as the filing by GAO Yuanqian, counted once

    10M HKD45HKEX
    300,000 shares@ HK$33.30340.085% mcap100.0% of flowShareXHKGHKEX:DA20261030E00114
    Canonical exit: 26 Jan 2027 (T+90)
  • ▲
    DirectorExecutives
    3M HKD34HKEX
    78,800 shares@ HK$32.93880.020% mcap3.8% of flowShareXHKGHKEX:DA20261029E00112
    Canonical exit: 25 Jan 2027 (T+90)
  • ▲
    DirectorExecutives

    Same trade as the filing by GAO Yuanqian, counted once

    3M HKD42HKEX
    78,800 shares@ HK$32.93880.020% mcap100.0% of flowShareXHKGHKEX:DA20261029E00106
    Canonical exit: 25 Jan 2027 (T+90)
  • ▲
    DirectorExecutives
    2M HKD33HKEX
    56,400 shares@ HK$31.60930.014% mcap2.7% of flowShareXHKGHKEX:DA20261027E00552
    Canonical exit: 21 Jan 2027 (T+90)
  • ▲
    DirectorExecutives
    7M HKD37HKEX
    217,600 shares@ HK$31.25680.053% mcap10.4% of flowShareXHKGHKEX:DA20261027E00551
    Canonical exit: 20 Jan 2027 (T+90)
  • ▲
    DirectorExecutives

    Same trade as the filing by GAO Yuanqian, counted once

    2M HKD35HKEX
    56,400 shares@ HK$31.60930.014% mcap20.8% of flowShareXHKGHKEX:DA20261027E00549
    Canonical exit: 21 Jan 2027 (T+90)
  • ▲
    DirectorExecutives

    Same trade as the filing by GAO Yuanqian, counted once

    7M HKD44HKEX
    217,600 shares@ HK$31.25680.053% mcap79.2% of flowShareXHKGHKEX:DA20261027E00547
    Canonical exit: 20 Jan 2027 (T+90)
  • ▲
    DirectorExecutives
    4M HKD36HKEX
    131,500 shares@ HK$31.93830.034% mcap7.4% of flowShareXHKGHKEX:DA20261026E00224
    Canonical exit: 19 Jan 2027 (T+90)
  • ▲
    DirectorExecutives

    Same trade as the filing by GAO Yuanqian, counted once

    4M HKD43HKEX
    131,500 shares@ HK$31.93830.034% mcap100.0% of flowShareXHKGHKEX:DA20261026E00219
    Canonical exit: 19 Jan 2027 (T+90)
  • ▲
    DirectorExecutives
    5M HKD36HKEX
    152,300 shares@ HK$31.06310.039% mcap9.0% of flowShareXHKGHKEX:DA20261022E00461
    Canonical exit: 14 Jan 2027 (T+90)
  • ▲
    DirectorExecutives

    Same trade as the filing by GAO Yuanqian, counted once

    5M HKD43HKEX
    152,300 shares@ HK$31.06310.039% mcap100.0% of flowShareXHKGHKEX:DA20261022E00456
    Canonical exit: 14 Jan 2027 (T+90)
  • ▲
    DirectorExecutives

    Same trade as the filing by GAO Yuanqian, counted once

    331,000 HKD32HKEX
    10,000 shares@ HK$33.100.0028% mcap5.4% of flowShareXHKGHKEX:DA20261016E00527
    Canonical exit: 12 Jan 2027 (T+90)
  • ▲
    DirectorExecutives
    6M HKD37HKEX
    187,200 shares@ HK$30.97360.049% mcap12.2% of flowShareXHKGHKEX:DA20261016E00537
    Canonical exit: 13 Jan 2027 (T+90)
  • ▲
    DirectorExecutives
    331,000 HKD31HKEX
    10,000 shares@ HK$33.100.0028% mcap0.7% of flowShareXHKGHKEX:DA20261016E00536
    Canonical exit: 12 Jan 2027 (T+90)
  • ▲
    DirectorExecutives

    Same trade as the filing by GAO Yuanqian, counted once

    6M HKD44HKEX
    187,200 shares@ HK$30.97360.049% mcap94.6% of flowShareXHKGHKEX:DA20261016E00529
    Canonical exit: 13 Jan 2027 (T+90)
  • ▲
    DirectorExecutives
    5M HKD37HKEX
    156,900 shares@ HK$32.94920.043% mcap12.5% of flowShareXHKGHKEX:DA20261015E00057
    Canonical exit: 11 Jan 2027 (T+90)
  • ▲
    DirectorExecutives
    5M HKD37HKEX
    164,800 shares@ HK$32.98220.045% mcap13.1% of flowShareXHKGHKEX:DA20261015E00055
    Canonical exit: 10 Jan 2027 (T+90)
  • ▲
    DirectorExecutives

    Same trade as the filing by GAO Yuanqian, counted once

    5M HKD41HKEX
    156,900 shares@ HK$32.94920.043% mcap48.9% of flowShareXHKGHKEX:DA20261015E00053
    Canonical exit: 11 Jan 2027 (T+90)
  • ▲
    DirectorExecutives

    Same trade as the filing by GAO Yuanqian, counted once

    5M HKD41HKEX
    164,800 shares@ HK$32.98220.045% mcap51.1% of flowShareXHKGHKEX:DA20261015E00052
    Canonical exit: 10 Jan 2027 (T+90)
  • ▲
    DirectorExecutives
    8M HKD38HKEX
    255,900 shares@ HK$32.77390.065% mcap27.1% of flowShareXHKGHKEX:DA20261013E00046
    Canonical exit: 7 Jan 2027 (T+90)

25 of 40 declarations

About Shenzhen Edge Medical Co., Ltd. - B - H Shares

Shenzhen Edge Medical Co., Ltd. is a company focused on the development and manufacturing of medical devices. It is listed on the stock market under B and H shares.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations